(Q46221113)
Statements
1 reference
The JAK2(V617F) tyrosine kinase mutation identifies clinically latent myeloproliferative disorders in patients presenting with hepatic or portal vein thrombosis (English)
1 reference
C Goulding
1 reference
B Uttenthal
1 reference
L Foroni
1 reference
V Duke
1 reference
A Traore
1 reference
P Kottaridis
1 reference
A V Hoffbrand
1 reference
D Patch
1 reference
C McNamara
1 reference
1 October 2008
1 reference
30
1 reference
5
1 reference
415-419
1 reference